Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akiko Chiba

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
American Journal of Surgery|September 9, 2025
Risk assessment tools for women with breast atypia: A systematic reviewTori C Nierenberg, Juliet C Dalton, Rylan Howell, et al.
Annals of Surgical Oncology|September 25, 2016
Trends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor-Positive Breast Cancer: A National Cancer Data Base StudyAkiko Chiba, Tanya L Hoskin, Courtney N Heins, et al.
American Journal of Surgery|October 20, 2023
Rates of high-risk screening prior to a breast cancer diagnosis in patients under age 40Christine Pestana, Ashley Cairns, Hsu Fang-Chi, et al.
The American Surgeon|April 13, 2022
Impact of the COVID-19 Pandemic on Breast Cancer Screening and Operative TreatmentAshley Cairns, V Morgan Jones, Kelly Cronin, et al.
Annals of Surgical Oncology|July 8, 2024
Demographics and Clinical Decision Making in Patients with Germline Moderate Penetrance Non-BRCA Mutations in Breast Cancer Related GenesKoumani W Ntowe, Samantha M Thomas, Juliet C Dalton, et al.
Bioorganic & Medicinal Chemistry|October 7, 2008
An endoplasmic reticulum (ER) stress-suppressive compound and its analogues from the mushroom Hericium erinaceumKeiko Ueda, Megumi Tsujimori, Shinya Kodani, et al.
American Journal of Surgery|June 22, 2025
The association of race and ethnicity with risk-reducing mastectomies in patients with non-BRCA mutationsKoumani W Ntowe, Samantha M Thomas, Juliet C Dalton, et al.
The American Surgeon|August 21, 2020
Is Excisional Biopsy Needed for Pure FEA Diagnosed on a Core Biopsy?Jennifer L Miller-Ocuin, Brett B Fowler, Daniel L Coldren, et al.
Breast Cancer Research and Treatment|November 21, 2025
Risk prediction models for malignancy upgrade in high-risk breast lesions: a qualitative systematic reviewJuliet C Dalton, Tori C Nierenberg, Austin Leonard, et al.
American Journal of Surgery|October 11, 2024
The association of genetic testing timing and mutation type on breast cancer management in patients with breast cancer-related mutationsEbunoluwa J Olunuga, Samantha M Thomas, Koumani W Ntowe, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
American Journal of Surgery|September 9, 2025
Risk assessment tools for women with breast atypia: A systematic reviewTori C Nierenberg, Juliet C Dalton, Rylan Howell, et al.
Annals of Surgical Oncology|September 25, 2016
Trends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor-Positive Breast Cancer: A National Cancer Data Base StudyAkiko Chiba, Tanya L Hoskin, Courtney N Heins, et al.
American Journal of Surgery|October 20, 2023
Rates of high-risk screening prior to a breast cancer diagnosis in patients under age 40Christine Pestana, Ashley Cairns, Hsu Fang-Chi, et al.
The American Surgeon|April 13, 2022
Impact of the COVID-19 Pandemic on Breast Cancer Screening and Operative TreatmentAshley Cairns, V Morgan Jones, Kelly Cronin, et al.
Annals of Surgical Oncology|July 8, 2024
Demographics and Clinical Decision Making in Patients with Germline Moderate Penetrance Non-BRCA Mutations in Breast Cancer Related GenesKoumani W Ntowe, Samantha M Thomas, Juliet C Dalton, et al.
Bioorganic & Medicinal Chemistry|October 7, 2008
An endoplasmic reticulum (ER) stress-suppressive compound and its analogues from the mushroom Hericium erinaceumKeiko Ueda, Megumi Tsujimori, Shinya Kodani, et al.
American Journal of Surgery|June 22, 2025
The association of race and ethnicity with risk-reducing mastectomies in patients with non-BRCA mutationsKoumani W Ntowe, Samantha M Thomas, Juliet C Dalton, et al.
The American Surgeon|August 21, 2020
Is Excisional Biopsy Needed for Pure FEA Diagnosed on a Core Biopsy?Jennifer L Miller-Ocuin, Brett B Fowler, Daniel L Coldren, et al.
Breast Cancer Research and Treatment|November 21, 2025
Risk prediction models for malignancy upgrade in high-risk breast lesions: a qualitative systematic reviewJuliet C Dalton, Tori C Nierenberg, Austin Leonard, et al.
American Journal of Surgery|October 11, 2024
The association of genetic testing timing and mutation type on breast cancer management in patients with breast cancer-related mutationsEbunoluwa J Olunuga, Samantha M Thomas, Koumani W Ntowe, et al.
Pageof 11